Allogene Therapeutics (ALLO) Interest & Investment Income (2021 - 2026)
Allogene Therapeutics recorded quarterly Interest & Investment Income of $3.6 million in Q1 2026, down 2.38% quarter-over-quarter from $3.7 million in Q4 2025, and down 35.22% year-over-year from $5.5 million in Q1 2025.
Allogene Therapeutics' Interest & Investment Income history runs 6 years deep, the most recent figure standing at $3.6 million for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 35.22% year-over-year to $3.6 million; the TTM figure through Mar 2026 stood at $17.3 million (down 14.28% YoY), while the FY2025 annual figure was $19.3 million, down 4.29% from the prior year.
- Interest & Investment Income came in at $3.6 million for Q1 2026 at Allogene Therapeutics, down from $3.7 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $6.7 million in Q3 2024 to a low of $315000.0 in Q2 2022.
- A 5-year average of $3.9 million and a median of $3.8 million in 2023 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income jumped 1382.26% in 2022 and sank 51.68% in 2024, its largest moves.
- Allogene Therapeutics' Interest & Investment Income stood at $2.8 million in 2022, then surged by 127.24% to $6.3 million in 2023, then tumbled by 51.68% to $3.0 million in 2024, then increased by 20.91% to $3.7 million in 2025, then fell by 2.38% to $3.6 million in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $3.6 million, $3.7 million, and $3.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Allogene Therapeutics | 521.43 Mn | 521.43 Mn | - | 3.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.57 Mn |
| Dec 31, 2025 | 3.66 Mn |
| Sep 30, 2025 | 3.93 Mn |
| Jun 30, 2025 | 6.19 Mn |
| Mar 31, 2025 | 5.52 Mn |
| Dec 31, 2024 | 3.03 Mn |
| Sep 30, 2024 | 6.71 Mn |
| Jun 30, 2024 | 4.99 Mn |
| Mar 31, 2024 | 5.43 Mn |
| Dec 31, 2023 | 6.27 Mn |
| Sep 30, 2023 | 6.21 Mn |
| Jun 30, 2023 | 3.78 Mn |
| Mar 31, 2023 | 2.06 Mn |
| Dec 31, 2022 | 2.76 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Jun 30, 2022 | 315,000.00 |
| Mar 31, 2022 | 492,000.00 |
| Dec 31, 2021 | 186,000.00 |
| Sep 30, 2021 | 393,000.00 |
| Jun 30, 2021 | 624,000.00 |